| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.066 | 0.1 |